Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.66 EUR | +3.91% | +3.10% | +25.47% |
10:57am | Immutep, Merck Collaborate on Trial for Lung Cancer Therapy | MT |
07:20am | Immutep, Merck Partner for Efti and Keytruda Combo in Lung Cancer Trial | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- IMM Stock
- YP1A Stock
- Revisions Immutep ADR